|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 161.37 USD | -1.23% |
|
-2.57% | +54.04% |
| Nov. 12 | DaVita Inc. Presents at UBS Global Healthcare Conference 2024, Nov-12-2024 12:30 PM | |
| Nov. 06 | Truist Securities Cuts Price Target on DaVita to $170 From $175, Maintains Hold Rating | MT |
| Capitalization | 13.23B 12.52B 11.63B 10.37B 18.56B 1,121B 20.55B 144B 53.38B 459B 49.66B 48.61B 1,987B | P/E ratio 2024 * |
16.7x | P/E ratio 2025 * | 15.3x |
|---|---|---|---|---|---|
| Enterprise value | 23.6B 22.33B 20.75B 18.5B 33.11B 1,999B 36.65B 257B 95.22B 819B 88.58B 86.7B 3,544B | EV / Sales 2024 * |
1.85x | EV / Sales 2025 * | 1.8x |
| Free-Float |
47.14% | Yield 2024 * |
-
| Yield 2025 * | 1.03% |
More valuation ratios
* Estimated data
More news
Last Transcript: DaVita Inc.
More recommendations
More press releases
| 1 day | -1.23% | ||
| 1 week | -2.57% | ||
| Current month | -2.89% | ||
| 1 month | +9.72% | ||
| 3 months | +8.49% | ||
| 6 months | +11.27% | ||
| Current year | +54.04% |
1 week
161.29
166.59
1 month
146.96169.52
Current year
103.40169.52
1 year
103.40169.52
3 years
65.28169.52
5 years
62.20169.52
10 years
43.40169.52
| Director | Title | Age | Since |
|---|---|---|---|
Javier Rodriguez
CEO | Chief Executive Officer | 53 | 2019-05-31 |
Joel Ackerman
DFI | Director of Finance/CFO | 59 | 2017-02-26 |
Alan Cullop
CIO | Chief Investment Officer | - | 2012-01-03 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pamela Arway
CHM | Chairman | 70 | 2020-05-31 |
Charles Berg
BRD | Director/Board Member | 66 | 2007-02-28 |
Barbara Desoer
BRD | Director/Board Member | 71 | 2015-10-07 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 15.19% | 380 M€ | +10.15% | - | |
| 1.89% | 16 M€ | -3.37% | ||
| 0.93% | 2 M€ | -.--% | ||
| 0.67% | 8 M€ | +5.48% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|
| -1.23% | -2.57% | +54.26% | +63.26% | 13.23B | ||
| -1.25% | -1.67% | +26.75% | +39.13% | 81.07B | ||
| -2.05% | -5.17% | -19.94% | -37.43% | 71.55B | ||
| +1.26% | +7.46% | +0.77% | +72.16% | 26.88B | ||
| -2.86% | +0.34% | +190.01% | +95.26% | 22.31B | ||
| -0.09% | +2.66% | +18.28% | +1.55% | 20.22B | ||
| -1.05% | -2.99% | +8.24% | -19.09% | 19.65B | ||
| -1.07% | -2.94% | +17.52% | +0.93% | 17.69B | ||
| +2.08% | +10.20% | +20.70% | -15.23% | 14.18B | ||
| -1.84% | -2.17% | +97.92% | +95.50% | 13.21B | ||
| Average | -1.07% | +0.38% | +41.45% | +29.61% | 30B | |
| Weighted average by Cap. | -1.23% | -0.87% | +27.16% | +20.38% |
| 2024 * | 2025 * | |
|---|---|---|
| Net sales | 12.75B 12.07B 11.21B 10B 17.89B 1,081B 19.81B 139B 51.46B 443B 47.87B 46.85B 1,915B | 13.23B 12.51B 11.63B 10.37B 18.56B 1,121B 20.54B 144B 53.36B 459B 49.64B 48.58B 1,986B |
| Net income | 836M 791M 735M 655M 1.17B 70.81B 1.3B 9.09B 3.37B 29.01B 3.14B 3.07B 125B | 848M 802M 745M 665M 1.19B 71.81B 1.32B 9.22B 3.42B 29.42B 3.18B 3.11B 127B |
| Net Debt | 10.37B 9.81B 9.12B 8.13B 14.55B 878B 16.1B 113B 41.83B 360B 38.92B 38.09B 1,557B | 10.63B 10.05B 9.34B 8.33B 14.91B 900B 16.5B 116B 42.87B 369B 39.89B 39.04B 1,596B |
More financial data
* Estimated data
Employees
70,000
Calendar
2025-02-17
- Q4 2024 Earnings Release (Projected)
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-12-05 | 161.37 $ | -1.23% | 447,332 |
| 24-12-04 | 163.38 $ | -0.38% | 413,823 |
| 24-12-03 | 164.01 $ | +0.16% | 523,459 |
| 24-12-02 | 163.74 $ | -1.46% | 694,842 |
| 24-11-29 | 166.17 $ | +0.33% | 314,276 |
Delayed Quote Nyse, December 05, 2024 at 04:00 pm EST
More quotes
Sell
Buy
Mean consensus
HOLD
Number of Analysts
9
Last Close Price
161.37USD
Average target price
156.90USD
Spread / Average Target
-2.77%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- DVA Stock